Mesothelin (MSLN), a glycoprotein membrane whose expression is limited to mesothelial cells, is overexpressed in most pancreatic cancers and is involved in tumor adhesion and dissemination, making it a robust therapeutic target [95,96]. Here, MSLN is linked to neoplasm.